The permission was given on December 28, 2020
Directorate General of Drug Administration (DGDA) has given permission to Globe Biotech Limited to manufacture their Covid-19 vaccine, Bongavax, for clinical trial.
The permission was given on December 28, 2020, confirmed Dr Asif Mahmud, in-charge of Molecular and Cell Biology unit and assistant manager of Globe Biotech Limited.
“Within a week, we will apply at Bangladesh Medical Research Council (BMRC) for ethical permission and hopefully by next month we can go for clinical trial,” said an official of Globe Biotech.
On December 1, 2020, Globe Biotech, the only Bangladeshi company that has claimed progress in developing a Covid-19 vaccine, announced that they will part ways with International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) for conducting human trials of their vaccine.
Globe Biotech cancelled the Memorandum of Understanding (MoU) as they observed less progress in icddr,b’s approach to conducting the human trial.